ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 257 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $832,000 | -57.3% | 23,338 | -44.8% | 0.00% | -50.0% |
| Q2 2023 | $1,950,238 | +141.7% | 42,277 | +110.1% | 0.01% | +100.0% |
| Q1 2023 | $806,852 | -54.4% | 20,121 | -47.3% | 0.00% | -50.0% |
| Q4 2022 | $1,770,316 | +24.1% | 38,211 | +11.0% | 0.01% | -14.3% |
| Q3 2022 | $1,426,000 | -8.6% | 34,438 | +31.6% | 0.01% | 0.0% |
| Q2 2022 | $1,561,000 | +219.9% | 26,176 | +289.3% | 0.01% | +250.0% |
| Q1 2022 | $488,000 | -74.2% | 6,724 | -59.6% | 0.00% | -75.0% |
| Q1 2021 | $1,895,000 | -69.7% | 16,645 | -63.1% | 0.01% | -70.4% |
| Q4 2020 | $6,250,000 | +133.3% | 45,148 | +38.5% | 0.03% | +145.5% |
| Q3 2020 | $2,679,000 | +19.9% | 32,593 | +14.1% | 0.01% | 0.0% |
| Q2 2020 | $2,235,000 | +34.7% | 28,577 | -23.5% | 0.01% | 0.0% |
| Q1 2020 | $1,659,000 | -59.6% | 37,348 | -61.2% | 0.01% | -21.4% |
| Q4 2019 | $4,107,000 | +87.0% | 96,143 | +87.2% | 0.01% | +75.0% |
| Q3 2019 | $2,196,000 | -48.8% | 51,346 | -24.0% | 0.01% | -50.0% |
| Q2 2019 | $4,290,000 | -20.4% | 67,563 | -13.1% | 0.02% | -20.0% |
| Q1 2019 | $5,389,000 | +188.0% | 77,705 | +80.5% | 0.02% | +150.0% |
| Q4 2018 | $1,871,000 | -50.4% | 43,043 | -12.8% | 0.01% | -42.9% |
| Q3 2018 | $3,770,000 | – | 49,384 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 437,512 | $31,772,000 | 2.80% |
| RTW INVESTMENTS, LP | 1,373,284 | $99,728,000 | 2.06% |
| Rock Springs Capital Management LP | 1,028,109 | $74,661,000 | 1.88% |
| Privium Fund Management B.V. | 112,727 | $8,186,000 | 1.81% |
| Avidity Partners Management LP | 869,000 | $63,107,000 | 1.31% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 525,100 | $38,133,000 | 1.16% |
| Boxer Capital, LLC | 200,000 | $14,524,000 | 0.75% |
| SECTOR GAMMA AS | 46,221 | $3,357,000 | 0.73% |
| FEDERATED HERMES, INC. | 3,987,728 | $289,589,000 | 0.65% |
| EMERALD ADVISERS, LLC | 223,952 | $16,263,000 | 0.62% |